The end of a shortage of popular weight-loss drugs may mean many people lose access to them
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC WEIGHT MANAGEMENT PROGRAM. WE ARE AT A CROSSROADS HERE WHERE WE HAVE MILLIONS OF PATIENTS THAT QUALIFY FOR THIS CLASS OF MEDICATION ...
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its WeightWatchers Clinic members, expanding the accessibility of popular weight loss medications to its members at a more affordable price.
WeightWatchers to offer compounded GLP-1 weight-loss drugs
WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy.
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance plans, a new survey shows.
Only about 1/5 of large companies cover drugs for weight loss
A survey of employers finds that only about a fifth of large companies cover drugs like Wegovy for weight loss. A majority of companies that do cover the medicines have requirements.
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and lucrative—tirzepatide drugs, namely knockoffs of Mounjaro for diabetes and Zepbound for weight loss.
Popular Weight Loss Drugs To Become More Expensive As Shortage Ends
With the shortage over, compounding pharmacies are no longer allowed to produce the popular weight loss drugs.
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
WeightWatchers rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'
WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...
Compounded Semaglutide: Is It Safe and Effective?
Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
WW International: The Party Won't Last Long
WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...
NBC Bay Area1d
Surging demand leaves many without crucial diabetes and ADHD medications
The FDA has issued warnings about the risks of compounded semaglutide. Ren-Fielding and her team often ask visiting ...
Washingtonians share how they afford pricey weight loss medications
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...
WW International surges as Morgan Stanley says GLP-1 entry 'not too late'
WW International (NASDAQ:WW) shares surged more than 20% in early trading on Wednesday after Morgan Stanley said the ...